BRPI0410998A - derivados de indol com efeito de indução de apoptose - Google Patents

derivados de indol com efeito de indução de apoptose

Info

Publication number
BRPI0410998A
BRPI0410998A BRPI0410998-8A BRPI0410998A BRPI0410998A BR PI0410998 A BRPI0410998 A BR PI0410998A BR PI0410998 A BRPI0410998 A BR PI0410998A BR PI0410998 A BRPI0410998 A BR PI0410998A
Authority
BR
Brazil
Prior art keywords
indole derivatives
apoptosis inducing
inducing effect
medicaments
derivatives
Prior art date
Application number
BRPI0410998-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Matthias Gerlach
Tilmann Schuster
Peter Emig
Peter Schmidt
Silke Bassner
Eckhard Guenther
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03012868A external-priority patent/EP1484329A1/fr
Priority claimed from EP04011598A external-priority patent/EP1595878A1/fr
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of BRPI0410998A publication Critical patent/BRPI0410998A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0410998-8A 2003-06-05 2004-05-25 derivados de indol com efeito de indução de apoptose BRPI0410998A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47627703P 2003-06-05 2003-06-05
EP03012868A EP1484329A1 (fr) 2003-06-06 2003-06-06 Dérivés d'indole déstinés à l'induction d'apoptose
EP04011598A EP1595878A1 (fr) 2004-05-15 2004-05-15 Derives d'indole destines a l'induction d'apoptose
PCT/EP2004/005593 WO2004108702A1 (fr) 2003-06-05 2004-05-25 Derives indoliques possedant une activite d'induction de l'apoptose

Publications (1)

Publication Number Publication Date
BRPI0410998A true BRPI0410998A (pt) 2006-07-04

Family

ID=43661564

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410998-8A BRPI0410998A (pt) 2003-06-05 2004-05-25 derivados de indol com efeito de indução de apoptose

Country Status (12)

Country Link
EP (1) EP1641777A1 (fr)
JP (1) JP4878285B2 (fr)
KR (1) KR101132599B1 (fr)
CN (1) CN1816543B (fr)
AU (1) AU2004245198B2 (fr)
BR (1) BRPI0410998A (fr)
CA (1) CA2526663C (fr)
MX (1) MXPA05013121A (fr)
NZ (1) NZ543853A (fr)
RS (1) RS20050901A (fr)
RU (1) RU2327696C2 (fr)
WO (1) WO2004108702A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007054556A1 (fr) * 2005-11-11 2007-05-18 Æterna Zentaris Gmbh Nouvelle pyridopyrazine et son utilisation pour la modulation de kinases
EP1790342A1 (fr) 2005-11-11 2007-05-30 Zentaris GmbH Dérivés de pyridopyrazine et leur utilisation comme modulateurs de transduction de signal
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
EP1956910B1 (fr) * 2005-11-23 2014-09-17 The Board of Regents of The University of Texas System Compose cytotoxique speficique du ras oncogene et ses procedes d'utilisation
EP2049520A4 (fr) * 2006-08-07 2011-01-05 Ironwood Pharmaceuticals Inc Composés d'indole
US20080241274A1 (en) * 2006-11-28 2008-10-02 Ziopharm Oncology, Inc. Indibulin therapy
UA106214C2 (ru) * 2008-10-16 2014-08-11 Эррей Биофарма Инк. Ингибиторы митоза для интенсификации процесса апоптоза при терапии
WO2012017325A2 (fr) * 2010-07-19 2012-02-09 Procaps Sa Dispositif et procédé pour encapsuler des microparticules avec du liquide dans des capsules molles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
TWI269654B (en) * 1999-09-28 2007-01-01 Baxter Healthcare Sa N-substituted indole-3-glyoxylamide compounds having anti-tumor action
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
IT1318641B1 (it) * 2000-07-25 2003-08-27 Novuspharma Spa Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale.
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
AU2002323474B2 (en) * 2001-09-13 2006-10-05 Synta Pharmaceuticals Corp 3-glyoxlylamideindoles for treating cancer

Also Published As

Publication number Publication date
RU2327696C2 (ru) 2008-06-27
CA2526663A1 (fr) 2004-12-16
MXPA05013121A (es) 2006-03-17
KR101132599B1 (ko) 2012-06-21
NZ543853A (en) 2009-09-25
CN1816543B (zh) 2011-01-19
JP2007523850A (ja) 2007-08-23
EP1641777A1 (fr) 2006-04-05
CA2526663C (fr) 2011-07-19
RS20050901A (en) 2007-12-31
JP4878285B2 (ja) 2012-02-15
CN1816543A (zh) 2006-08-09
RU2006100022A (ru) 2006-05-27
AU2004245198A1 (en) 2004-12-16
WO2004108702A1 (fr) 2004-12-16
AU2004245198B2 (en) 2009-04-23
KR20060034230A (ko) 2006-04-21

Similar Documents

Publication Publication Date Title
DE50310516D1 (de) Fredericamycin-derivate
LTPA2016034I1 (lt) Brutono tirozinkinazės inhibitoriai
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
CL2008001932A1 (es) Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer.
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
CY1107054T1 (el) Ενωσεις διτοσυλικου αλατος κιναζολινης
BRPI0608297A2 (pt) composições de lipossomos
ATE305300T1 (de) Verwendung von cyclopamine, zur behandlung des basalzellkarzinoms und anderer tumoren
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
HK1124546A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
TW200642682A (en) A combination of medical drugs to augment the anti-cancer effect of chemotherapy
ATE448232T1 (de) Substituierte heterozyklen
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
BR0209645A (pt) Oxazolo- e furopirimidinas e seu uso como medicamentos
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
GB0416508D0 (en) Therapeutic agents
BRPI0410998A (pt) derivados de indol com efeito de indução de apoptose
HUP0203197A2 (hu) Docetaxel alkalmazása hepatocelluláris karcinómák kezelésére
TW200626566A (en) 4, 7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses
ATE422905T1 (de) Verbandsmaterial mit wirkstoffen
JO2666B1 (en) Use of agomelatine for medications to treat bilateral mental disorders
BRPI0515533A (pt) forma de dosagem estável de derivados de fenilalanina

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25G Requested change of headquarter approved

Owner name: ZENTARIS GMBH (DE)

Free format text: SEDE ALTERADA CONFORME PETICAO NO 020060058923-RJ DE 27.04.2006.

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.